{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:07:38Z","timestamp":1770332858605,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":520,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001250","name":"Morris Animal Foundation","doi-asserted-by":"publisher","award":["D20CA-044"],"award-info":[{"award-number":["D20CA-044"]}],"id":[{"id":"10.13039\/100001250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001250","name":"Morris Animal Foundation","doi-asserted-by":"publisher","award":["D20CA\u2010044"],"award-info":[{"award-number":["D20CA\u2010044"]}],"id":[{"id":"10.13039\/100001250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrent bacterial cystitis, often referred to as recurrent urinary tract infection (UTI), can be difficult to manage and alternative treatments are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objective<\/jats:title>\n                    <jats:p>Intravesicular administration of asymptomatic bacteriuria (ASB) E. coli 212 will not be inferior to antimicrobial treatment for the management of recurrent UTI in dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Thirty-four dogs with &amp;gt;1 UTI in the 12\u2009months before presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All dogs were deemed normal otherwise based on absence of abnormalities on physical examination, CBC, serum biochemical panel, and abdominal ultrasonography. Dogs were randomized to 1 of 2 treatment groups: Group 1 antimicrobials for 7\u2009days or group 2 intravesicular administration of ASB E. coli 212. Owners were provided a voiding questionnaire regarding their dogs' clinical signs, which was completed daily for 14\u2009days to assess clinical cure. Dogs were examined on days 7 and 14 to assess clinical cure, and urine specimens were submitted for urinalysis and bacterial culture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical cure rates for ASB E. coli 212\u2013treated dogs were not inferior to 7\u2009days of antimicrobial treatment with a 12% margin of difference to determine non-inferiority. No significant difference was found between the treatment groups on days 7 and 14 in the proportion of dogs achieving \u226550% or \u226575% reduction in their clinical score compared with baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>These data suggest that intravesicular administration of ASB E. coli 212 is not inferior to antimicrobials for the treatment of recurrent UTI in dogs. This biotherapeutic agent could help alleviate the need for antimicrobials for some dogs with recurrent UTI, improving antimicrobial stewardship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.17167","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T15:35:36Z","timestamp":1726587336000},"page":"2548-2555","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the efficacy of a live\n                    <i>Escherichia coli<\/i>\n                    biotherapeutic product (asymptomatic bacteriuria\n                    <i>E. coli<\/i>\n                    212)"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4714-3159","authenticated-orcid":false,"given":"Gilad","family":"Segev","sequence":"first","affiliation":[{"name":"Koret School of Veterinary Medicine, The Hebrew University of Jerusalem , Jerusalem,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-9484","authenticated-orcid":false,"given":"Hilla","family":"Chen","sequence":"additional","affiliation":[{"name":"Koret School of Veterinary Medicine, The Hebrew University of Jerusalem , Jerusalem,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-1442","authenticated-orcid":false,"given":"Jonathan D.","family":"Dear","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California, Davis Department of Medicine and Epidemiology, , Davis, California,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mart\u00ednez L\u00f3pez","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California, Davis Department of Medicine and Epidemiology, , Davis, California,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jully","family":"Pires","sequence":"additional","affiliation":[{"name":"Veterinary Center for Clinical Trials, University of California, Davis , Davis, California,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Klumpp","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Northwestern University Department of Urology, , Evanston, Illinois,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Schaeffer","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Northwestern University Department of Urology, , Evanston, Illinois,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1287-3979","authenticated-orcid":false,"given":"Jodi L.","family":"Westropp","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California, Davis Department of Medicine and Epidemiology, , Davis, California,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"key":"2026020505520963000_jvim17167-bib-0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2019.03.003","article-title":"Pre-test probability of urinary tract infection in dogs with clinical signs of lower urinary tract disease","volume":"247","author":"Sorensen","year":"2019","journal-title":"Vet J"},{"key":"2026020505520963000_jvim17167-bib-0002","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/jvim.15728","article-title":"Transurethral cystoscopy in dogs with recurrent urinary tract infections: retrospective study (2011-2018)","volume":"34","author":"Llido","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0003","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/jvim.16040","article-title":"Diagnostic accuracy of a point-of-care test using voided urine samples for detection of bacteriuria in dogs with signs of lower urinary tract disease","volume":"35","author":"Grant","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0004","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1939-1676.2012.00914.x","article-title":"Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs","volume":"26","author":"Westropp","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/jvim.13571","article-title":"Antimicrobial susceptibility patterns in urinary tract infections in dogs (2010-2013)","volume":"29","author":"Wong","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0006","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1292\/jvms.13-0281","article-title":"Antimicrobial resistance of Escherichia coli isolates from canine urinary tract infections","volume":"77","author":"Chang","year":"2015","journal-title":"J Vet Med Sci"},{"key":"2026020505520963000_jvim17167-bib-0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/vr.d4784","article-title":"Antimicrobial resistance: time for action","volume":"169","author":"Weese","year":"2011","journal-title":"Vet Rec"},{"key":"2026020505520963000_jvim17167-bib-0008","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/BF01700414","article-title":"Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in southern Israel, 1991-1995","volume":"16","author":"Weber","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026020505520963000_jvim17167-bib-0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109321","article-title":"Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI","volume":"9","author":"Rudick","year":"2014","journal-title":"PLoS One"},{"key":"2026020505520963000_jvim17167-bib-0010","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0022-5347(05)67823-8","article-title":"Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients","volume":"163","author":"Hull","year":"2000","journal-title":"J Urol"},{"key":"2026020505520963000_jvim17167-bib-0011","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/497272","article-title":"Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial","volume":"41","author":"Darouiche","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026020505520963000_jvim17167-bib-0012","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/jvim.14851","article-title":"Evaluation of the live biotherapeutic product, asymptomatic bacteriuria Escherichia coli 2-12, in healthy dogs and dogs with clinical recurrent UTI","volume":"32","author":"Segev","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0013","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2460\/javma.2005.226.1676","article-title":"Corynebacterium urealyticum urinary tract infection in dogs and cats: 7 cases (1996-2003)","volume":"226","author":"Bailiff","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020505520963000_jvim17167-bib-0014","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2885.2006.00801.x","article-title":"Pharmacokinetics and pharmacodynamics of cefovecin in dogs","volume":"29","author":"Stegemann","year":"2006","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020505520963000_jvim17167-bib-0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1745-6215-12-106","article-title":"Through the looking glass: understanding non-inferiority","volume":"12","author":"Schumi","year":"2011","journal-title":"Trials"},{"key":"2026020505520963000_jvim17167-bib-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linteral mixed-effects models urine IMe4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"2026020505520963000_jvim17167-bib-0017","article-title":"Descriptive interpretations of confidence intervals. R package version 1.0.0. 2017","author":"Vine"},{"key":"2026020505520963000_jvim17167-bib-0018","article-title":"Tools for the analysis of epidemiological data. R package version 2.0.70. 2024","author":"Stevenson"},{"key":"2026020505520963000_jvim17167-bib-0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.vetmic.2010.06.007","article-title":"Experimental colonization of the canine urinary tract with the asymptomatic bacteriuria Escherichia coli strain 83972","volume":"147","author":"Thompson","year":"2011","journal-title":"Vet Microbiol"},{"key":"2026020505520963000_jvim17167-bib-0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vetmic.2012.03.012","article-title":"A modified three-dose protocol for colonization of the canine urinary tract with the asymptomatic bacteriuria Escherichia coli strain 83972","volume":"158","author":"Thompson","year":"2012","journal-title":"Vet Microbiol"},{"key":"2026020505520963000_jvim17167-bib-0021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2307\/2531438","article-title":"Planning and monitoring of equivalence studies","volume":"46","author":"Durrleman","year":"1990","journal-title":"Biometrics"},{"key":"2026020505520963000_jvim17167-bib-0022","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jts.20367","article-title":"Noninferiority and equivalence designs: issues and implications for mental health research","volume":"21","author":"Greene","year":"2008","journal-title":"J Trauma Stress"},{"key":"2026020505520963000_jvim17167-bib-0023","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-132-9-200005020-00006","article-title":"Claims of equivalence in medical research: are they supported by the evidence?","volume":"132","author":"Greene","year":"2000","journal-title":"Ann Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0024","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/jvim.12324","article-title":"Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitis","volume":"28","author":"Clare","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020505520963000_jvim17167-bib-0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tvjl.2019.02.008","article-title":"International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats","volume":"247","author":"Weese","year":"2019","journal-title":"Vet J"},{"key":"2026020505520963000_jvim17167-bib-0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","volume":"25","author":"Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"key":"2026020505520963000_jvim17167-bib-0027","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/jvim.16501","article-title":"Diagnostic yield of uroendoscopy compared to ultrasonography for evaluating lower urinary tract disorders in dogs","volume":"36","author":"Hsieh","year":"2022","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/38\/5\/2548\/66662244\/jvim17167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/38\/5\/2548\/66662244\/jvim17167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:52:18Z","timestamp":1770288738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/38\/5\/2548\/8448520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.17167","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,9,1]]},"assertion":[{"value":"2024-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}